← SynDRA
CKI-7
SynDRA canonical compound SYN1970027 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
| Primary target(s) | CSNK1G2 |
| Mechanism of action | casein kinase inhibitor |
All known targets
Mechanisms of action (all sources)
Cross-references
Synonyms
- CKI 7
- N-(2-Aminoethyl)-5-chloroisoquinoline-8-sulfonamide
- N-(2-Aminoethyl)-5-chloroisoquinoline-8-sulphonamide
- CKI-7 (free base)
- UNII-3IE84W82O5
- CHEBI:47322
- 3IE84W82O5
- 8-Isoquinolinesulfonamide,N-(2-aminoethyl)-5-chloro-
- 8-Isoquinolinesulfonamide, N-(2-aminoethyl)-5-chloro-
- 2csn
- CKI
- ACMC-20efrf
- CHEMBL489157
- Isoquinolinesulfonamide, CKI-7
- SCHEMBL3491587
- BDBM92674
- DTXSID20152934
- ZINC6415144
- MFCD00269886
- AKOS027446743
- DB03693
- NCGC00165762-01
- DB-082055
- HY-133028
- B4936
- CS-0109499
- FT-0661792
- Y7241
- W-205095
- N-(2-aminoethyl)-5-chloro-isoquinoline-8-sulfonamide
- Q27094604
- 5-Chloro-isoquinoline-8-sulfonic acid, (2-amino-ethyl)-amide
Look up CKI-7 in the interactive SynDRA portal →